These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 6418888

  • 1. 8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists.
    Arvidsson LE, Hacksell U, Johansson AM, Nilsson JL, Lindberg P, Sanchez D, Wikström H, Svensson K, Hjorth S, Carlsson A.
    J Med Chem; 1984 Jan; 27(1):45-51. PubMed ID: 6418888
    [Abstract] [Full Text] [Related]

  • 2. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.
    Arvidsson LE, Johansson AM, Hacksell U, Nilsson JL, Svensson K, Hjorth S, Magnusson T, Carlsson A, Andersson B, Wikström H.
    J Med Chem; 1987 Nov; 30(11):2105-9. PubMed ID: 2959776
    [Abstract] [Full Text] [Related]

  • 3. Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
    Mellin C, Björk L, Karlén A, Johansson AM, Sundell S, Kenne L, Nelson DL, Andén NE, Hacksell U.
    J Med Chem; 1988 Jun; 31(6):1130-40. PubMed ID: 2967376
    [Abstract] [Full Text] [Related]

  • 4. C1-Methylated 5-hydroxy-2-(dipropylamino)tetralins: central dopamine-receptor stimulating activity.
    Hacksell U, Johansson AM, Arvidsson L, Nilsson JL, Hjorth S, Carlsson A, Wikström H, Sanchez D, Lindberg P.
    J Med Chem; 1984 Aug; 27(8):1003-7. PubMed ID: 6431102
    [Abstract] [Full Text] [Related]

  • 5. Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists.
    Johansson AM, Arvidsson LE, Hacksell U, Nilsson JL, Svensson K, Carlsson A.
    J Med Chem; 1987 Apr; 30(4):602-11. PubMed ID: 3560156
    [Abstract] [Full Text] [Related]

  • 6. Structural factors of importance for 5-hydroxytryptaminergic activity. Conformational preferences and electrostatic potentials of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and some related agents.
    Arvidsson LE, Karlén A, Norinder U, Kenne L, Sundell S, Hacksell U.
    J Med Chem; 1988 Jan; 31(1):212-21. PubMed ID: 2961887
    [Abstract] [Full Text] [Related]

  • 7. C3-methylated 5-hydroxy-2-(dipropylamino)tetralins: conformational and steric parameters of importance for central dopamine receptor activation.
    Johansson AM, Nilsson JL, Karlén A, Hacksell U, Svensson K, Carlsson A, Kenne L, Sundell S.
    J Med Chem; 1987 Jul; 30(7):1135-44. PubMed ID: 3599021
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 5-Hydroxy-2-methyl-2-(di-n-propylamino)tetralin: synthesis and central pharmacological effects.
    Hacksell U, Arvidsson LE, Johansson AM, Nilsson JL, Sanchez D, Andersson B, Lindberg P, Wikström H, Hjorth S, Svensson K.
    Acta Pharm Suec; 1985 Jul; 22(2):65-74. PubMed ID: 2996294
    [No Abstract] [Full Text] [Related]

  • 10. A C2-methylated derivative of the 5-hydroxy-tryptamine-receptor agonist 8-hydroxy-2-(dipropylamino)tetralin (8-OH DPAT).
    Mellin C, Liu Y, Hacksell U, Björk L, Andén NE.
    Acta Pharm Suec; 1987 Jul; 24(4):153-60. PubMed ID: 2964167
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[[trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the formation of active metabolites in vivo.
    Sonesson C, Boije M, Svensson K, Ekman A, Carlsson A, Romero AG, Martin IJ, Duncan JN, King LJ, Wikström H.
    J Med Chem; 1993 Oct 29; 36(22):3409-16. PubMed ID: 8230131
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of the C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on central 5-hydroxytryptamine receptors.
    Björk L, Mellin C, Hacksell U, Andén NE.
    Eur J Pharmacol; 1987 Nov 03; 143(1):55-63. PubMed ID: 2961582
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain.
    Hamon M, Bourgoin S, Gozlan H, Hall MD, Goetz C, Artaud F, Horn AS.
    Eur J Pharmacol; 1984 May 04; 100(3-4):263-76. PubMed ID: 6203761
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.